A Fairfield man was sentenced to 30 months in federal prison for his role in a $7.8 million fraud and kickback scheme ...
COVID-era financial assistance for ObamaCare health plans are all but guaranteed to lapse at the end of the year.
Shelton biotech Intensity Therapeutics paused its Phase 3 cancer trial after running low on cash. The company needs $30M to finish testing INT230-6, an injectable drug that attacks tumors directly.
Feature a new hire, promotion, or accolade through Hartford Business and showcase your people to the most prominent business leader in the area. Submit your Movers & Shakers announcement here.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback